Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

Journal of Clinical Investigation

Volumn 90, Issue 2, 1992, Pages 533-536

  Spinas, Glatgen A ^a   Keller, Ulrich ^a   Brockhaus, Manfred ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cyclooxygenase inhibitor; Human; Ibuprofen; Lipopolysaccharide; Tumor necrosis factor binding protein

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; IBUPROFEN; MONOCLONAL ANTIBODY; RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; PRIORITY JOURNAL;

ADULT; BACTERIAL TOXINS; ENDOTOXINS; ESCHERICHIA COLI; HUMAN; IBUPROFEN; MALE; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0026737258     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115891     Document Type: Article

References (26)

1. Tracey, K. J., H. Vlassara, and A. Cerami. 1989. Cachectin/tumour necrosis factor. Lancet, i:1122-1125.
2. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science (Wash. DC). 234:470-474.
3. Grau, G. E., L. F. Fajardo, P.-F. Piguet, B. Allet, P.-H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (Wash. DC). 237:1210-1212.
4. Seckinger, P., S. Isaaz, and J.-M. Dayer. 1988. A human inhibitor to tumor necrosis factor α. J. Exp. Med. 167:1511-1516.
5. Peetre, C., H. Thysell, A. Grubb, and I. Olsson. 1988. A tumor necroses factor binding protein is present in human biological fluids. Eur. J. Haematol. 41:414-419.
6. Lantz, M., S. Malik, M. L. Slevin, and I. Olsson. 1990. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine. 2:402-406.
7. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531-1536.
8. Kohno, T., M. T. Brewer, S. L. Baker, P. E. Schwartz, M. W. King, K. K. Hale, C. H. Squires, R. C. Thompson, and J. L. Vannice. 1990. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA. 87:8331-8335.
9. Brockhaus, M., H. J. Schoenfeld, E. J. Schlaeger, W. Hunziker. W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 87:3127-3131.
10. Hohmann, H. P., R. Remy, M. Brockhaus, and A. P. G. M. van Loon. 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J. Biol. Chem. 264:14927-14934.
11. Ryffel, B., M. Brockhaus, U. Dürmüller, and F. Gudat. 1991. TNF receptors in lymphoid tissues and lymphomas: source and site of action of tumor necrosis factor α (TNFα). Am. J. Pathol. 139:7-15.
12. Porteu, F., and C. F. Nathan. 1990. Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172:599-607.
13. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyler, C. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
14. Martich, G. D., R. L. Danner, M. Ceska, and A. F. Suffredini. 1991. Detection of Interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 173:1021-1024.
15. Spinas, G. A., D. Bloesch, U. Keller, W. Zimmerli, and S. Cammisuli. 1991. Pretreatment with ibuprofen augments circulating tumor necrosis factor-α, interleukin-6 and elastase during acute endotoxinemia. J. Infect. Dis. 163:89-95.
16. Spinas, G. A., D. Bloesch, M.-T. Kaufmann, U. Keller, and J.-M. Dayer. 1990. Induction of plasma inhibitors of interleukin 1 and TNF-α by endotoxin administration to normal humans. Am. J. Physiol. R993-R997.
17. Digel, W., F. Porzsolt, M. Schmid, F. Herrmann, W. Lesslauer, and M. Brockhaus. 1992. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and B-type chronic lymphocytic leukemia. J. Clin. Invest. 89:1690-1693.
18. Porteu, F., M. Brockhaus, D. Wallach, H. Engelmann, and C. F. Nathan. 1991. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem. 266:18846-18853.
19. Loetscher, H., R. Gentz, M. Zulauf, A. Lustig, H. Tabuchi, J. Schlaeger, M. Brockhaus, H. Gallati, M. Manneberg, and W. Lesslauer. 1991. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNFα and TNFβ and inhibition of TNF activity. J. Biol. Chem. 266:18324-18329.
20. Peck, R., M. Brockhaus, and J. Frey. 1989. Cell surface tumor necrosis factor (TNF) accounts for monocyte-and lymphocytes-mediated killing of TNF-resistent target cells. Cell. Immunol. 122:1-10.
21. Aderka, D., H. Engelmann, V. Hornik, Y. Skornick, Y. Levo, D. Wallach, and G. Kushtai. 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51:5602-5607.
22. Dembic, Z., H. Loetscher, U. Gubler, Y.-C. E. Pan, H.-W. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 2:231-237.
23. Lantz, M., U. Gullbverg, E. Nilsson, and I. Olsson. 1990. Characterization in vitro of a human tumor necrosis factor-binding protein. J. Clin. Invest. 86:1396-1402.
24. Hohmann, H., M. Brockhaus, P. Baeuerle, R. Remy, R. Kolbeck, and A. P. G. M. van Loon. 1990. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kB. J. Biol. Chem. 265:22409-22417.
25. Engelberts, I., S. Stephens, G. J. M. Francot, C. J. van der Linden, and W. A. Buurman. 1991. Evidence of different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet. 338:515-516.
26. Kriegler, M., C. Perez, K. DeFay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53:45-53.